Working... Menu
Trial record 20 of 10870 for:    Placebo AND once

A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00751166
Recruitment Status : Terminated (Study could not be re-supplied with study medication in a timely manner.)
First Posted : September 11, 2008
Last Update Posted : March 24, 2017
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : May 1, 2005
  Actual Study Completion Date : May 1, 2005